Investing.com - Can Fite Biopharma ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Can Fite Biopharma ADR announced earnings per share of $0.00 on revenue of $148K. Analysts polled by Investing.com anticipated EPS of $-0.145 on revenue of $300K.
Can Fite Biopharma ADR shares are up 11% from the beginning of the year and are trading at $2.090 , down-from-52-week-high.They are under-performing the S&P Merval which is up 12.1% from the start of the year.
Can Fite Biopharma ADR shares lost 2.34% in intra-day trade the report.
Can Fite Biopharma ADR follows other major sector earnings this month
Can Fite Biopharma ADR's report follows an earnings beat by Tencent ADR on May 20, who reported EPS of $0.7642 on revenue of $21.03B, compared to forecasts EPS of $0.536 on revenue of $20.58B.
Industrial Commercial Bank of China had beat expectations on April 29 with first quarter EPS of $0.7417 on revenue of $33.09B, compared to forecast for EPS of $0.6343 on revenue of $34.72B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar